Predictive impact of serous retinal detachment in refractory diabetic macular edema
Abstract Background Anti-vascular endothelial growth factor (VEGF) drugs are the first-line treatment option for DME management. However, part of DME was refractory to anti-VEGF medicine. With promotion of imaging technology, various retinal morphological characteristics are considered to be related...
Saved in:
| Main Authors: | Zhuo-hua Zhou, Lu Zhao, Yan-ling Wang, Jia-lin Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-04-01
|
| Series: | BMC Ophthalmology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12886-025-03993-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patterns of Foveal Eversion in Patients with Diabetic Macular Edema
by: E. Yu. Santoro, et al.
Published: (2025-03-01) -
Analysis of the central zone of the retina in patients with diabetic macular edema
by: Mukharram Muhtaramovich Bikbov, et al.
Published: (2015-12-01) -
Incidence of Clinical and Subclinical Cystoid Macular Edema in Diabetic and Non-Diabetic Patients After Cataract Surgery by Means of Optical Coherence Tomography
by: Aditi Chinmay Deshpande, et al.
Published: (2018-10-01) -
Serum Apolipoprotein B and B/A1 Ratio as Early Negative Biomarkers for OCT- and OCTA-Detected Retinal Changes in Diabetic Macular Edema
by: Soedarman S, et al.
Published: (2025-07-01) -
Exploring the role of hyperreflective walls as a biomarker for the management of cystoid macular edema
by: Zhang-Rong Yang, et al.
Published: (2025-09-01)